Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Published:2016-12-24 Issue:3 Volume:15 Page:269-275
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Al-Tawfiq Jaffar A.¹²,Memish Ziad A.³⁴

Affiliation:

1. Specialty Internal Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Kingdom of Saudi Arabia

2. Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA

3. Department of Medicine, Ministry of Health, Riyadh, Kingdom of Saudi Arabia

4. Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2017.1271712

Reference72 articles.

1. Managing MERS-CoV in the healthcare setting

2. Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus

3. Middle East respiratory syndrome coronavirus in healthcare settings

4. Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapy

5. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An in silico approach to develop potential therapies against Middle East Respiratory Syndrome Coronavirus (MERS-CoV);Heliyon;2024-02

2. Evaluation of Predicted siRNA as an Antiviral against MERS-CoV Targeting the Membrane Gene in the Vero Cell Line;Microbiology Research;2023-10-17

3. Exploring the pharmacological aspects of natural phytochemicals against SARS-CoV-2 Nsp14 through an in silico approach;In Silico Pharmacology;2023-04-28

4. DENTAL QUALITY OF LIFE SCORE OHIP-49-RU IN PATIENTS WITH LABORATORY-CONFIRMED SARS-COV-2 DIAGNOSIS;Actual problems in dentistry;2022-08-18

5. Significant perspectives on various viral infections targeted antiviral drugs and vaccines including COVID-19 pandemicity;Molecular Biomedicine;2022-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3